Peptides UK

Research Peptides UK Glutathione Peptide UK: Biological Research and Evidence in the Peptides UK Market Glutathione is a naturally synthesised three-amino-acid peptide found throughout human tissues. Its reduced form, commonly abbreviated to GSH, participates in redox regulation, peroxide metabolism, protein-thiol protection and the handling of numerous reactive compounds. Glutathione has a far more established biological role than most products discussed within the Peptides UK market, but its essential cellular function does not prove that every supplement, nasal product, infusion or injectable formulation produces a meaningful...

Research Peptides UK Epithalon Peptide UK: Epitalon Research in the Peptides UK Market Epithalon, more commonly written as Epitalon in scientific and regulatory documents, is the synthetic four-amino-acid peptide Ala-Glu-Asp-Gly. It was developed from research into Epithalamin, a complex peptide extract originally obtained from bovine pineal tissue. Laboratory and animal studies have investigated telomerase, telomere length, melatonin rhythms, ageing biomarkers, retinal degeneration and tumour development. These findings do not establish Epithalon as a human longevity, sleep, anti-ageing or disease treatment. Author: It’s Me & You...

Research Peptides UK SS-31 Peptide UK: Elamipretide Evidence in the Peptides UK Market SS-31 is an early research name for elamipretide, a synthetic aromatic-cationic tetrapeptide designed to localise at the inner mitochondrial membrane. It is also known historically as MTP-131 and Bendavia. Elamipretide interacts with cardiolipin, a phospholipid required for mitochondrial membrane organisation and energy production. In September 2025, a defined elamipretide prescription product received accelerated FDA approval for improving muscle strength in a narrow group of patients with Barth syndrome. That approval does not...

Research Peptides UK AOD-9604 Peptide UK: Evidence in the Peptides UK Market AOD-9604 is a synthetic, disulphide-bridged 16-amino-acid peptide created from human growth-hormone residues 177–191 with an additional N-terminal tyrosine. Its sequence is YLRIVQCRSVEGSCGF. It is chemically distinct from native hGH Fragment 176–191, which begins with phenylalanine. AOD-9604 was developed as a potential obesity medicine after rodent experiments reported changes in fat oxidation and lipid metabolism, but the human obesity programme did not establish clinically meaningful weight loss and was discontinued. It remains promoted online...